Petrovax announces positive results from long-CoV-III-21 trial of Longidaza for long-term pulmonary sequelae of COVID-19

Dec 19, 2024 - 06:00

Petrovax announces positive results from long-CoV-III-21 trial of Longidaza for long-term pulmonary sequelae of COVID-19

Read the original article

Tags:

Previous Article

Abera and Orexo partner for vaccine powder formulations

Oncology R&D: emerging therapies and new challenges

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

STAT+: Dana-Farber executive says split from Mass General will benefit patients

STAT+: Dana-Farber executive says split from Mass Gener...

Oct 18, 2023

Psychedelic treatments for mental health: Is there substance behind the hype?

Psychedelic treatments for mental health: Is there subs...

Feb 16, 2024

Novo Nordisk invests $1.2bn in new Denmark facility

Novo Nordisk invests $1.2bn in new Denmark facility

Dec 19, 2024